Compugen (CGEN) Total Current Liabilities (2009 - 2026)
Compugen recorded quarterly Total Current Liabilities of $22.0 million in Q1 2026, down 2.36% quarter-over-quarter from $22.6 million in Q4 2025.
Compugen's Total Current Liabilities history runs 11 years deep, the most recent figure standing at $22.0 million for Q1 2026.
- In Q1 2026, Total Current Liabilities changed N/A year-over-year to $22.0 million; the TTM figure through Mar 2026 stood at $22.0 million (changed N/A YoY), while the FY2025 annual figure was $22.6 million, up 11.95% from the prior year.
- Total Current Liabilities came in at $22.0 million for Q1 2026 at Compugen, down from $22.6 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $26.3 million in Q4 2023 to a low of $11.9 million in Q4 2022.
- A 5-year average of $20.6 million and a median of $22.0 million in 2026 frame the typical range for Total Current Liabilities.
- Across the five-year window, Total Current Liabilities tumbled 30.28% in 2022 and soared 120.37% in 2023, its largest moves.
- Compugen's Total Current Liabilities stood at $11.9 million in 2022, then jumped by 120.37% to $26.3 million in 2023, then slipped by 23.25% to $20.2 million in 2024, then climbed by 11.95% to $22.6 million in 2025, then dropped by 2.36% to $22.0 million in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $22.0 million, $22.6 million, and $20.2 million for Q1 2026, Q4 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 16.35 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.70 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 636.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 66.94 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 13.42 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 3.88 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 5.11 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.35 Bn |
| 10 | Compugen | 234.03 Mn | 142.28 Mn | 352,000.00 | 22.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.04 Mn |
| Dec 31, 2025 | 22.57 Mn |
| Sep 30, 2025 | 20.28 Mn |
| Jun 30, 2025 | 20.58 Mn |
| Mar 31, 2025 | 20.99 Mn |
| Dec 31, 2024 | 20.16 Mn |
| Sep 30, 2024 | 27.76 Mn |
| Jun 30, 2024 | 24.77 Mn |
| Mar 31, 2024 | 24.63 Mn |
| Dec 31, 2023 | 26.27 Mn |
| Sep 30, 2023 | 10.38 Mn |
| Jun 30, 2023 | 10.80 Mn |
| Mar 31, 2023 | 10.72 Mn |
| Dec 31, 2022 | 11.92 Mn |
| Sep 30, 2022 | 14.77 Mn |
| Jun 30, 2022 | 14.00 Mn |
| Mar 31, 2022 | 15.70 Mn |
| Dec 31, 2021 | 17.10 Mn |
| Sep 30, 2021 | 15.26 Mn |
| Jun 30, 2021 | 11.85 Mn |
| Mar 31, 2021 | 11.38 Mn |
| Dec 31, 2020 | 10.52 Mn |
| Sep 30, 2020 | 7.92 Mn |
| Jun 30, 2020 | 8.06 Mn |
| Mar 31, 2020 | 8.71 Mn |
| Dec 31, 2019 | 6.82 Mn |
| Sep 30, 2019 | 6.73 Mn |
| Jun 30, 2019 | 7.02 Mn |
| Mar 31, 2019 | 7.77 Mn |
| Dec 31, 2018 | 9.99 Mn |
| Sep 30, 2018 | 9.66 Mn |
| Jun 30, 2018 | 7.50 Mn |
| Mar 31, 2018 | 5.51 Mn |
| Dec 31, 2017 | 6.19 Mn |
| Sep 30, 2017 | 5.85 Mn |
| Jun 30, 2017 | 5.07 Mn |
| Mar 31, 2017 | 5.25 Mn |
| Dec 31, 2016 | 4.74 Mn |
| Sep 30, 2016 | 4.65 Mn |
| Jun 30, 2016 | 4.54 Mn |
| Mar 31, 2016 | 5.78 Mn |
| Dec 31, 2015 | 6.85 Mn |
| Sep 30, 2015 | 5.14 Mn |
| Jun 30, 2015 | 5.25 Mn |
| Mar 31, 2015 | 5.24 Mn |
| Dec 31, 2014 | 6.59 Mn |
| Sep 30, 2014 | 5.11 Mn |
| Jun 30, 2014 | 6.81 Mn |
| Mar 31, 2014 | 8.37 Mn |
| Dec 31, 2013 | 7.74 Mn |
| Sep 30, 2013 | 9.21 Mn |
| Jun 30, 2013 | 2.08 Mn |
| Mar 31, 2013 | 1.77 Mn |
| Dec 31, 2012 | 1.38 Mn |
| Sep 30, 2012 | 1.75 Mn |
| Jun 30, 2012 | 1.54 Mn |
| Mar 31, 2012 | 2.10 Mn |
| Dec 31, 2011 | 1.42 Mn |
| Sep 30, 2011 | 1.38 Mn |
| Jun 30, 2011 | 1.26 Mn |
| Mar 31, 2011 | 1.60 Mn |
| Dec 31, 2010 | 2.44 Mn |
| Sep 30, 2010 | 1.21 Mn |
| Jun 30, 2010 | 1.15 Mn |
| Mar 31, 2010 | 1.59 Mn |
| Dec 31, 2009 | 1.47 Mn |
| Sep 30, 2009 | 1.29 Mn |
| Jun 30, 2009 | 1.34 Mn |
| Mar 31, 2009 | 1.40 Mn |